By analyzing tumors from patients treated with immunotherapy for advanced kidney cancer in three clinical trials, Dana-Farber Cancer Institute scientists have identified several features of the tumors that influence their response to immune...
28-May-2020 11:05 AM EDT Add to Favorites
Phyllis F. Cantor Center for Research in Nursing and Patient Care Services awarded two major research grants
Nurse-scientists from the Phyllis F. Cantor Center for Research in Nursing and Patient Care Services at Dana-Farber Cancer Institute received more than $1.3 million dollars in funding for two separate research projects.
26-May-2020 2:20 PM EDT Add to Favorites
Scientists at Dana-Farber Cancer Institute have launched a clinical test of a blood cancer drug in patients infected with the COVID-19 virus.
19-May-2020 8:00 AM EDT Add to Favorites
Long before multiple myeloma becomes a malignant disease, the collection of immune system cells and signal carriers amid the tumor cells undergoes dramatic shifts, with alterations in both the number and type of immune cells, researchers at...
24-Apr-2020 3:05 PM EDT Add to Favorites
The American Society of Clinical Oncology (ASCO) recognized four Dana-Farber Cancer Institute researchers as winners of ASCO's Special Awards, the Society’s highest honors. The recipients of these awards have worked to transform cancer care...
24-Apr-2020 4:25 PM EDT Add to Favorites
New targeted agent produces considerable responses in trial with patients with uterine serous carcinoma
The DNA repair-blocking drug adavosertib shrinks tumors in nearly one-third of patients in clinical trial. Data will be shared virtually at the Society for Gynecologic Oncology (SGO) Annual Meeting on Women’s Cancer.
21-Apr-2020 2:30 PM EDT Add to Favorites
SHE Center at Dana-Farber and Silverberry Genomix form SHE Biobank, a Population Health Initiative for Research and Education
Dana-Farber and Silverberry Genomix launch the SHE Biobank initiative -- a long-term study to investigate the impact of genetic predisposition and environmental exposure to development of disease.
23-Apr-2020 2:05 PM EDT Add to Favorites
Massive study reveals how “hypermutated” malignant brain tumors with many mutations escape chemotherapy and immunotherapy
An analysis of more than 10,000 gliomas and clinical outcomes reported in Nature by scientists in Boston and Paris found that glioma patients whose tumors were hypermutated actually had no significant benefit when treated with checkpoint blockers.
15-Apr-2020 1:55 PM EDT Add to Favorites
See All News
With March marking Colorectal Cancer Awareness Month, here are the answers to some key questions about Colon cancer.
5-Mar-2014 5:00 PM EST
11-Nov-2013 5:00 PM EST
National Cancer Report Underscores Need for Research Funding; Dana-Farber Expert Says Scientific Advances Merit Support
17-Sep-2013 3:00 PM EDT
The Human papillomavirus, or HPV, and its link to certain cancers has been in the headlines recently, reigniting the debate whether it is appropriate to vaccinate children against the virus. Robert Haddad, MD, the disease center lead at...
7-Jun-2013 12:00 PM EDT
24-May-2013 3:00 PM EDT
Prom season and summer approach, and with them teenage girls seeking suntans. New research published in the May issue of Pediatrics finds that the number of children diagnosed with melanoma has increased an average 2% a year since the 1970s.
17-May-2013 8:00 AM EDT
The holidays are almost here and festive food is everywhere. “While these foods are delicious to eat, some have the added bonus of containing cancer-preventing nutrients,” says Stephanie Meyers, MS, RD/LDN, a nutritionist at Dana-Farber Cancer...
23-Oct-2009 1:00 PM EDT